Saudi Arabia Revolutionizes Healthcare with First AI Doctor Clinic
A Chinese startup has launched the world’s first AI-powered clinic in Saudi Arabia, revolutionizing how patients receive medical care. Synyi AI, a Shanghai-based medical technology company, partnered with Almoosa Health Group to introduce this innovative trial program in Al-Ahsa. The clinic aims to replace human doctors as the first point of contact for diagnosing and treating patients.
Patients visiting the clinic interact with an AI doctor named “Dr. Hua” through a tablet, describing their symptoms in detail. The AI follows up with specific questions and analyzes medical data, such as X-rays and cardiograms, with assistance from human staff. After the consultation, Dr. Hua provides a treatment plan, which a human doctor reviews and approves. Human doctors remain available for emergencies that AI cannot handle.
Promising Results and Future Expansion
During initial testing, the AI system demonstrated an error rate of less than 0.3%, showcasing its potential for accurate diagnoses. So far, dozens of patients have used the service free of charge, with human doctors supervising the process. Synyi AI plans to expand the clinic’s capabilities to cover 50 diseases, including respiratory, gastroenterological, and dermatological conditions, within the next year.
The pilot program is generating diagnostic data for submission to Saudi authorities, with commercial approval expected within 18 months. However, some medical professionals remain skeptical about AI replacing human doctors. Ngiam Kee Yuan, a senior consultant at Singapore’s National University Hospital, expressed doubts about AI reaching the level of primary practitioners anytime soon.
AI in the Middle East: A Growing Trend
Synyi AI is part of a broader wave of Chinese health-tech companies entering the Middle East to refine their technologies. Shanghai Fosun Pharmaceutical Group recently partnered with Saudi Arabia’s Fakeeh Care Group to advance tele-diagnostics and gene therapy. Similarly, XtalPi Holdings is establishing a robotics lab in the UAE to further AI-driven medical research.
Experts emphasize the need for strict oversight to ensure safety and public trust in medical AI. Dylan Attard, CEO of MedTech World, highlighted the importance of balancing thorough regulation with adaptability to avoid stifling innovation.
Synyi AI’s CEO, Zhang Shaodian, believes AI can significantly reduce healthcare costs, especially in regions where medical services are expensive or scarce. He envisions AI increasing efficiency tenfold, particularly in remote areas lacking medical staff. With Saudi Arabia as its first overseas market, Synyi AI is paving the way for a new era in global healthcare.
